In yesterday’s Wall Street session, Klotho Neurosciences Inc (NASDAQ:KLTO) shares traded at $0.60, down -14.22% from the previous session.
KLTO stock price is now 37.73% away from the 50-day moving average and -80.49% away from the 200-day moving average. The market capitalization of the company currently stands at $10.94M.
In other news, CHARDAN CAPITAL MARKETS LLC, 10% Owner sold 180,000 shares of the company’s stock on Jul 02 ’24. The stock was sold for $368,442 at an average price of $2.05. Upon completion of the transaction, the 10% Owner now directly owns 1,284,364 shares in the company, valued at $0.77 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 01 ’24, 10% Owner CHARDAN CAPITAL MARKETS LLC sold 115,136 shares of the business’s stock. A total of $237,618 was realized by selling the stock at an average price of $2.06. This leaves the insider owning 1,464,364 shares of the company worth $0.88 million. A total of 22.45% of the company’s stock is owned by insiders.
During the past 12 months, Klotho Neurosciences Inc has had a low of $0.26 and a high of $13.10. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 0.16, and a quick ratio of 0.16. The fifty day moving average price for KLTO is $0.43566 and a two-hundred day moving average price translates $3.0779 for the stock.
The latest earnings results from Klotho Neurosciences Inc (NASDAQ: KLTO) was released for 2024-06-30. The company reported revenue of $2.87 million for the quarter, compared to $0.12 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2215.32 percent.
